Allergan’s patent-protection deal with the Saint Regis Mohawk Tribe is under scrutiny from Congress, as the legislative body begins research into the agreement.
Allergan recently transferred its patents for Restasis (cyclosporine ophthalmic emulsion 0.05%) to the New-York based Native American tribe, which has sovereign immunity. Allergan will maintain exclusive licenses to the patents while paying the Saint Regis tribe $15 million annually.
A letter from members of the House Committee on Oversight and Government Reform to Brent Saunders, Allergan chairman, president and CEO, requests all
Uncategorized